Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.34 |
| ▸ | THRA | P10827 | 2/20 | 0.34 |
| ▸ | RARA | P10276 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906501 | 0.94 | NR1H4 (0.38) | HTTPOLBAPEX1TDP1NR1H4 | |
| SCHEMBL9906500 | 0.89 | HTT (0.47) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL12733767 | 0.89 | NR1H4 (0.36) | HTTPOLBAPEX1TDP1NR1H4 | |
| SCHEMBL816364 | 0.89 | HTT (0.47) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL816054 | 0.88 | HTT (0.47) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL816072 | 0.88 | POLB (0.47) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL15398119 | 0.87 | HTT (0.46) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL15398106 | 0.86 | HTT (0.45) | HTTPOLBAPEX1TDP1THRA | |
| SCHEMBL5844203 | 0.86 | POLB (0.58) | HTTPOLBAPEX1TDP1NR1H4 | |
| SCHEMBL815711 | 0.86 | POLB (0.45) | HTTPOLBAPEX1TDP1THRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2695930-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | DAINIPPON INK & CHEMICALS (JP) | 2019-09-11 | — | — | EP | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-8663497-B2 | Liquid crystal composition comprising polymerizable compound, and liquid crystal display element using said liquid crystal composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8663497-B2 | Liquid crystal composition comprising polymerizable compound, and liquid crystal display element using said liquid crystal composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| EP-2695930-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | Adeka Corporation (JP) | 2014-02-12 | — | — | EP | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| EP-2502973-A1 | LIQUID CRYSTAL COMPOSITION COMPRISING POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAID LIQUID CRYSTAL COMPOSITION | Adeka Corporation (JP) | 2012-09-26 | — | — | EP | disclosed |
| US-20120200794-A1 | LIQUID CRYSTAL COMPOSITION COMPRISING POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAID LIQUID CRYSTAL COMPOSITION | ADEKA CORPORATION (JP) | 2012-08-09 | — | — | US | disclosed |
| US-20120200794-A1 | LIQUID CRYSTAL COMPOSITION COMPRISING POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAID LIQUID CRYSTAL COMPOSITION | ADEKA CORPORATION (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8057701-B2 | Trifunctional (meth)acrylate compound and polymerizable composition containing same | ADEKA CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| US-8057701-B2 | Trifunctional (meth)acrylate compound and polymerizable composition containing same | ADEKA CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| EP-2261201-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE COMPOUND | Adeka Corporation (JP) | 2010-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | PYM1, MT-CO1, MAT1A | HTT 2866/4885POLB 792/4885APEX1 1377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.